TruAlt Bioenergy's profit halves as revenue drops; no new catalysts in filing
Standalone net profit fell from ₹14,862 lakhs to ₹8,983 lakhs in FY26. The audited results confirm a known downtrend without new drivers.
— 3 earlier stories on TruAlt Bioenergy Ltd. →What's new
- FY26 standalone net profit dropped to ₹8,983 lakhs from ₹14,862 lakhs; EPS halved to ₹10.23.
- The consolidated financials also show a decline in both revenue and profit versus the prior year.
- No new strategic updates; previously disclosed partnerships and the Karnataka ethanol order were reiterated.
Why this matters
The filing is a routine but material disclosure of a sharp earnings decline. It adds no new catalysts to a story the market already knows, confirming a deteriorating financial trajectory without a clear near-term reversal plan.
What we're watching
- Whether the previously announced Karnataka ethanol and CBG deals generate meaningful FY27 revenue.
- The timeline for resolving the auditor's emphasis on pending asset componentisation.
- Next quarter's results for any sign of margin stabilization.
The full read
TruAlt Bioenergy's FY26 audited results confirm a sharp downturn. Standalone net profit fell to ₹8,983 lakhs from ₹14,862 lakhs, with EPS halving to ₹10.23. The consolidated financials show a similar decline. The strategic partnerships driving future growth were all disclosed previously. This filing adds no new catalysts. The auditor's report is unmodified but flags pending asset componentisation. The core issue is the gap between the company's prior profitability and its current results. Closing it depends on converting announced deals into booked revenue. Not yet.
Questions answered
- How much did TruAlt's standalone profit decline in FY26?
- Standalone net profit fell to ₹8,983 lakhs from ₹14,862 lakhs in the prior year, a drop of roughly 40%. EPS halved to ₹10.23.
- Were there any new business developments in this filing?
- No. The Karnataka High Court ethanol order, the Sumitomo and GAIL CBG partnerships, and the Honeywell SAF agreement were all disclosed in earlier filings and are reiterated here without update.
- What is the auditor's report flagging?
- The auditor's report is unmodified but includes an emphasis of matter regarding the pending componentisation of assets, a procedural note that does not qualify the financial statements.
- How do the consolidated results compare?
- Consolidated results mirror the standalone trend, showing a decline in both revenue and profit compared to the prior year.
TruAlt Bioenergy Ltd.
Latest quarter · Mar 2026
Strength & growth
Story so far
All notes on TRUALT →- 22 May 2026 · 5:31 PM IST TruAlt Bioenergy's profit halves as revenue drops; no new catalysts in filing
- today TruAlt Bioenergy lands ₹150 cr government grant for SAF plant
- 27d ago TruAlt Bioenergy pushes back SAF project as ethanol volumes miss targets
- 27d ago TruAlt Bioenergy FY26 profits drop to ₹8,983 lakhs